Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 79:e263–e421

Article  PubMed  Google Scholar 

Bourque CW, Oliet SH, Richard D (1994) Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol 15:231–274

Article  CAS  PubMed  Google Scholar 

McKinley MJ, Mathai ML, McAllen RM, McClear RC, Miselis RR, Pennington GL, Vivas L, Wade JD, Oldfield BJ (2004) Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis. J Neuroendocrinol 16:340–347

Article  CAS  PubMed  Google Scholar 

Goldsmith SR, Gheorghiade M (2005) Vasopressin antagonism in heart failure. J Am Coll Cardiol 46:1785–1791

Article  CAS  PubMed  Google Scholar 

Staub NC (1974) Pulmonary edema. Physiol Rev 54:678–811

Article  CAS  PubMed  Google Scholar 

Taylor AE, Guyton AC, Bishop VS (1965) Permeability of the alveolar membrane to solutes. Circ Res 16:353–362

Article  CAS  PubMed  Google Scholar 

Berthiaume Y, Broaddus VC, Gropper MA, Tanita T, Matthay MA (1988) Alveolar liquid and protein clearance from normal dog lungs. J Appl Physiol 65:585–593

Article  CAS  PubMed  Google Scholar 

Olivera WG, Ciccolella DE, Barquin N, Ridge KM, Rutschman DH, Yeates DB, Sznajder JI (2000) Aldosterone regulates Na, K-ATPase and increases lung edema clearance in rats. Am J Respir Crit Care Med 161:567–573

Article  CAS  PubMed  Google Scholar 

Azzam ZS, Adir Y, Crespo A, Comellas A, Lecuona E, Dada LA, Krivoy N, Rutschman DH, Sznajder JI, Ridge KM (2004) Norepinephrine increases alveolar fluid reabsorption and Na, K-ATPase activity. Am J Respir Crit Care Med 170:730–736

Article  PubMed  Google Scholar 

Guetta J, Klorin G, Tal R, Berger G, Ismael-Badarneh R, Bishara B, Sabo E, Abassi Z, Azzam ZS (2012) Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model. Am J Respir Cell Mol Biol 47:583–588

Article  CAS  PubMed  Google Scholar 

Chioncel O, Collins SP, Ambrosy AP, Gheorghiade M, Filippatos G (2015) Pulmonary oedema-therapeutic targets. Card Fail Rev 1:38–45

Article  PubMed  PubMed Central  Google Scholar 

Cosby RL, Sophocles AM, Durr JA, Perrinjaquet CL, Yee B, Schrier RW (1988) Elevated plasma atrial natriuretic factor and vasopressin in high-altitude pulmonary edema. Ann Intern Med 109:796–799

Article  CAS  PubMed  Google Scholar 

Lin Q, Fu F, Chen H, Zhu B (2012) Copeptin in the assessment of acute lung injury and cardiogenic pulmonary edema. Respir Med 106:1268–1277

Article  PubMed  Google Scholar 

Herrera EA, Riquelme RA, Sanhueza EM, Gajardo C, Parer JT, Llanos AJ (2000) Cardiovascular responses to arginine vasopressin blockade during acute hypoxemia in the llama fetus. High Alt Med Biol 1:175–184

Article  CAS  PubMed  Google Scholar 

Maggiorini M, Mélot C, Pierre S, Pfeiffer F, Greve I, Sartori C, Lepori M, Hauser M, Scherrer U, Naeije R (2001) High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 103:2078–2083

Article  CAS  PubMed  Google Scholar 

Rossi NF, Chen H, Musch TI (2002) Endothelin 1-induced pressor response and vasopressin release in rats with heart failure. J Cardiovasc Pharmacol 40:80–89

Article  CAS  PubMed  Google Scholar 

Goerre S, Wenk M, Bärtsch P, Lüscher TF, Niroomand F, Hohenhaus E, Oelz O, Reinhart WH (1995) Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 91:359–364

Article  CAS  PubMed  Google Scholar 

Hackett PH, Roach RC (2001) High-altitude illness. N Engl J Med 345:107–114

Article  CAS  PubMed  Google Scholar 

Azzam ZS, Sznajder JI (2015) Lung edema clearance: relevance to patients with lung injury. Rambam Maimonides Med J 6:e0025

Article  PubMed  PubMed Central  Google Scholar 

Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47:742–748

Article  CAS  PubMed  Google Scholar 

Biaggioni I, Shibao CA, Diedrich A, Muldowney JAS 3rd, Laffer CL, Jordan J (2019) Blood pressure management in afferent baroreflex failure: JACC review topic of the week. J Am Coll Cardiol 74:2939–2947

Article  PubMed  PubMed Central  Google Scholar 

Iovino M, Lisco G, Giagulli VA, Vanacore A, Pesce A, Guastamacchia E, De Pergola G, Triggiani V (2021) Angiotensin II-vasopressin interactions in the regulation of cardiovascular functions. evidence for an impaired hormonal sympathetic reflex in hypertension and congestive heart failure. Endocr Metab Immune Disord Drug Targets 21:1830–1844

Article  PubMed  Google Scholar 

Funakoshi K, Hosokawa K, Kishi T, Ide T, Sunagawa K (2014) Striking volume intolerance is induced by mimicking arterial baroreflex failure in normal left ventricular function. J Card Fail 20:53–59

Article  PubMed  Google Scholar 

Sakamoto K, Hosokawa K, Saku K, Sakamoto T, Tobushi T, Oga Y, Kishi T, Ide T, Sunagawa K (2016) Baroreflex failure increases the risk of pulmonary edema in conscious rats with normal left ventricular function. Am J Physiol Heart Circ Physiol 310:H199-205

Article  PubMed  Google Scholar 

Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82:1724–1729

Article  CAS  PubMed  Google Scholar 

Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R (2008) Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol 52:266–272

Article  CAS  PubMed  Google Scholar 

Balling L, Kistorp C, Schou M, Egstrup M, Gustafsson I, Goetze JP, Hildebrandt P, Gustafsson F (2012) Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses. J Card Fail 18:351–358

Article  CAS  PubMed  Google Scholar 

Chirinos JA, Sardana M, Oldland G, Ansari B, Lee J, Hussain A, Mustafa A, Akers SR, Wei W, Lakatta EG, Fedorova OV (2018) Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure. ESC Heart Fail 5:911–919

Article  PubMed  PubMed Central  Google Scholar 

Hage C, Lund LH, Donal E, Daubert JC, Linde C, Mellbin L (2015) Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study. Open Heart 2:e000260

Article  PubMed  PubMed Central  Google Scholar